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Abstract
Aim: To determine whether muscle function is compromised in healthy
smokers in comparison with activity-matched non-smokers.
Methods: Nine male smokers (aged 22.2  2.5 years: mean  SD) with a
smoking history of 2.5  3.1 pack years, and ten male control participants
(25.4  2.9 years) matched for physical activity level participated in this
study. Knee extensor strength was measured using isometric maximal vol-
untary contractions. Voluntary activation of the quadriceps and co-activa-
tion of the biceps femoris were determined using interpolated twitches and
surface electromyography respectively. The frequency–torque relationship
and fatigue resistance were assessed with electrically evoked contractions. A
fatigue index was determined as the ratio of final torque to initial torque
during a series of isometric contractions (2 min; 30 Hz; 1 s contraction/1 s
rest). Quadriceps anatomical cross sectional area was measured with MRI at
50% of femur length.
Results: Maximal voluntary contraction torque, quadriceps anatomical
cross sectional area, knee extensor torque/quadriceps cross sectional area,
activation, co-activation and force–frequency relationship were similar,
whereas the fatigue index was 17% lower in smokers than non-smokers.
Conclusion: In young men smoking does not significantly affect quadriceps
muscle mass and contractile properties, but does reduce fatigue resistance of
the quadriceps muscle, which was not attributable to differences in physical
activity.
Keywords contractile properties, electrical stimulation, isometric strength,
quadriceps cross-sectional area, smoking.
Smoking is a recognized risk factor for cardiovascular
disease, lung cancer and chronic obstructive pulmo-
nary disease (COPD). Many patients with COPD and
chronic heart failure suffer from muscle dysfunction,
which is not directly related to changes in lung or
heart function (Gosker et al. 2000). Besides muscle
wasting, which results in weakness (Franssen et al.
2005), there is a reduction in the oxidative capacity
(Gosker et al. 2000) and a shift towards faster fibre
types (Satta et al. 1997) which may explain the
reduced muscle endurance in COPD patients (Van’t
Hul et al. 2004).
In addition to damaging the lungs, smoking may also
affect skeletal muscle (Agusti et al. 2003, Gan et al.
2004, 2005). Smoking has been reported to cause a
decline in muscle strength (O¨rlander et al. 1979,
Al-Obaidi et al. 2004). As muscle cross-sectional area
is the major determinant of strength (Maughan et al.
1983) it is likely that the lower muscle strength in
smokers is attributable to a smaller muscle mass.
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However, where differences in muscle strength have
been reported between smokers and non-smokers,
muscle size has not been measured. Furthermore, a
shift from high-oxidative type 1 (slow-twitch) fibres
towards a higher percentage of low-oxidative type II
(fast-twitch) fibres and a reduction in mitochondrial
volume (O¨rlander et al. 1979) occurs; changes that are
likely to result in a reduction of fatigue resistance
(Degens & Veerkamp 1994). It has been suggested that
the differences in skeletal muscle between smokers and
non-smokers is at least partly due to a lower physical
activity level of smokers (O¨rlander et al. 1979). It is
important to minimize this bias when studying the
effects of smoking on skeletal muscle. Indeed, disuse
induces the same changes in skeletal muscle. Therefore,
it is important to take into account the physical activity
level to separate the effects of disuse from those of
smoking per se.
Thus, the aim of the present investigation was to
determine whether (i) smokers are weaker than non-
smokers, (ii) any weakness is the result of neural and/or
muscular factors, (iii) there is any difference in con-
tractile properties between smokers and non- smokers,
and (iv) fatigue resistance is altered in smokers com-
pared to non-smokers. To exclude the role of disuse,
control male participants were activity-matched with
healthy smokers. To circumvent possible differences in
motivation between smokers and non-smokers, elec-
trically evoked muscle contractions were used to test
muscle function. Considering the role of smoking in the
development of COPD and its potential effects on
skeletal muscle the present study may reveal changes in
skeletal muscle function of young healthy smokers (i.e.
free from any pre-existing medical condition) before
any clinical signs of COPD develop.
Methods
Participants
Nine male smokers and ten male non-smokers (Table 1)
participated in the study. Smokers and non-smokers
were matched for age and physical activity level.
Written informed consent was obtained from all
participants and all procedures were approved by the
Local Ethics Committee of Manchester Metropolitan
University. Potential participants who suffered from
respiratory, cardiovascular or neuromuscular diseases
or had any lower limb injury were excluded from the
study. All participants abstained from smoking and
caffeine ingestion for 2 h prior to testing. Physical
activity (PA) levels were assessed using a previously
validated questionnaire (Baecke et al. 1982); where 6
indicates a sedentary lifestyle and 12 a high physical
activity level. All participants were relatively inactive
with a mean score of around 8 for each group (Table 1).
Smoking history was assessed by questionnaire and
smoking volume was determined by pack-years, which
is defined as the number of cigarette packs smoked per
day, multiplied by the number of years smoking. The
vital capacity (VC) forced expiratory volume (FEV) was
assessed with spirometry (Vitalograph Ltd., Bucks, UK)
and used to determine the percentage of the age and
height adjusted predicted value (FEV1%pred) (Crapo
et al. 1981).
Experimental set-up
Participants were familiarized with the testing proce-
dures on a separate session prior to data collection. All
knee extension torque measurements were performed
on the right leg with a Cybex norm dynamometer
(Ronkonkoma, New York, NY, USA). Participants were
seated with the hip joint at 90  flexion with the hip and
shoulders strapped to prevent any extraneous movement.
Before the experiment, participants warmed-up by per-
forming five submaximal isokinetic contractions. Torque
was displayed on a computer screen, interfaced with an
acquisition system (acknowledge; Biopac Systems,
Santa Barbara, CA, USA) used for analogue-to-digital
conversion. The sampling frequency was 2000 Hz.
Each torque signal was filtered with a low-pass
fourth order Butterworth filter with a 30 Hz cut-off
frequency.
Isometric maximal voluntary contractions (MVC) torque
The optimal angle for torque generation appeared to be
at 80  (full knee extension ¼ 0 ) in all but two
participants (data not shown). Therefore, to reduce
the influence of joint angle on twitch characteristics all
subsequent measurements were performed at a knee
joint angle of 80 . MVCs were maintained for 4 s
(sufficient to reach a plateau) with 2 min of rest in
Table 1 Participant characteristics
Smokers
(n ¼ 9)
Non-smokers
(n ¼ 10)
Age (years) 22.2  2.5 25.4  2.9
Mass (kg) 79.9  14.0 76.1  8.7
Height (cm) 180.2  6.5 179.9  6.4
BMI (kg m)2) 26.6  2.3 23.5  1.5
VC (L) 4.4  0.8 5.0  0.6
FEV1%pred 91.3  13.7 104.7  9.9
Physical activity 8.3  1.6 8.7  1.5
Smoking history (pack years) 2.5  3.1 –
BMI, body mass index; VC, vital capacity; FEV1%pred, the
percentage of the age and height adjusted predicted FEV1.
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between each contraction to prevent development of
fatigue. To maximize performance, visual feedback of
the torque signal and verbal encouragement was given
to all participants. The highest torque reached during a
contraction was recorded, and the highest value of the
two contractions was given as the MVC.
Voluntary activation
Voluntary activation levels were determined with the
interpolated twitch technique as described previously
(Allen et al. 1995). Briefly, the muscle was stimulated
percutaneously, with the anode (76 mm · 127 mm;
Versastim, Conmed Corp., New York, NY, USA),
placed over the proximal region of the quadriceps and
the cathode over the distal third of the femur length. To
assess the supra-maximal current, single pulses (pulse
width 50 ls; DSV Digitimer Stimulator, Digitimer Ltd.,
Herts, UK) were administered at 30 s intervals with
increases in current of 5–10 mA, until no further
increase in torque was observed. For the interpolated
twitch technique, a first doublet (pulse width of 50 ls,
interpulse interval 10 ms) was applied with the parti-
cipant in a relaxed state and a second during the plateau
phase of the MVC. The ratio of interpolated and resting
doublets was used to provide an index of activation
(Allen et al. 1995) as follows:
Activation (%) ¼ ½1  ðsuperimposed doublet torque=
resting doublet torqueÞ  100;
where the superimposed doublet torque is the additional
torque during the MVC caused by the doublet.
Antagonist co-activation
To determine whether antagonist co-contraction affec-
ted the measured torque during a knee extensor MVC,
the electromyographic (EMG) activity of the biceps
femoris was recorded as described previously (Kellis &
Baltzopoulos 1997). Two 10-mm, pre-gelled, Ag-AgCl
percutaneous unipolar electrodes (Medicotest, Ol-
stykke, Denmark) were placed along the mid sagittal
line of the biceps femoris muscle to reduce the level of
cross talk. To ensure that EMG recordings were made
beyond the motor point of the biceps femoris, electrodes
were positioned at a third of total femur length (Zipp
1982), with the reference electrodes placed over the
lateral epicondyle of the femur. The raw EMG activity
was acquired with a sampling frequency of 2000 Hz
and processed with a multi channel analogue–digital
converter (Biopac Systems Inc., Santa Barbara, CA,
USA). The raw EMG signal was filtered with low and
high-band pass filters set at 500 and 10 Hz, respectively,
and amplified with a gain of 2000. The level of
co-activation of the biceps femoris was assessed using
the root mean square (RMS) of the raw EMG signal
which was integrated over 1 s about the peak MVC
torque during knee extension and was expressed as the
percentage of activity recorded from the biceps femoris
during maximal knee flexion (Klein et al. 2001).
Contractile properties
The frequency–torque relationship and fatigue resist-
ance were determined with electrically evoked contrac-
tions essentially as described previously (Degens et al.
2005). Briefly, the intensity of stimulation throughout
the test was such that about 30% of MVC toque was
developed during 100-Hz.
Five minutes after the last MVC, the quadriceps muscle
was stimulated with 1, 10, 15, 20, 30, 50 and 100-Hz
trains for 1 s, separated by 1 min, to assess the fre-
quency–torque relationship. Frequencies were delivered
in a random order. From the 100-Hz tetanus of the
frequency–torque relationship, the contraction time was
measured as the time from activation until 90% of the
maximal torque was reached, and the relaxation time as
the time for the torque to decline to 50% of maximal
torque after cessation of stimulation (Degens et al.2005).
Fatigue test
Five minutes after the contractions for the frequency–
torque relationship the resistance to fatigue was
assessed by stimulating the quadriceps muscle with
30-Hz trains, 1-s on 1-s off, for 2 min (Degens et al.
2005). Fatigue (FI) was expressed as the torque at the
end of the test divided by that at the start of the test.
Anatomical cross-sectional area
Anatomical cross-sectional area (ACSA) of the quadri-
ceps was measured with magnetic resonance imaging
(MRI), using a fixed 0.2-T MRI scanner (E-Scan; ESA-
OTE Biomedica, Genova, Italy), at 50% of femur length.
Scans were obtained with a T1 weighted, high resolution,
gradient echo profile, with the following scanning
parameters: time to echo – 16 ms; repetition time –
100 ms; field of view – 330 mm · 254 mm – matrix:
256 · 256, and a slice thickness of 5 mm. Subjects were
supine for 15 min prior to the scan to make sure any fluid
shifts had stabilized. To account for differences in muscle
mass between the two groups, knee extensor torque
was scaled with quadriceps ACSA (Maughan et al.
1983) and expressed as Torque/ACSA (Nm cm)2).
Statistical analysis
Data are reported as mean  SD. To determine the
effects of smoking an unpaired two-tailed Student’s
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t-test was performed. None of the parameters violated
the assumptions of the t-test except for Physical Activity
scores which were compared using a non-parametric
Mann–Whitney test. Differences were considered signi-
ficant at P < 0.05.
Results
Subject characteristics
Table 1 shows the subject characteristics. Body mass,
stature and body mass index (BMI) did not differ
between smokers and non-smokers (Table 1). The
smokers and non-smokers were successfully matched
for physical activity as the PA scores did not differ
significantly (Table 1). Smoking history ranged from
0.4–11.1 pack years, with a median of 1.7 years
(Table 1). The non-smokers had never smoked. VC
and FEV1%pred did not differ significantly between
smokers and non-smokers (Table 1).
Strength and muscle size
Knee extensor MVC torque was not significantly
different between smokers and non-smokers (Table 2).
This and the similar ACSA were reflected in the absence
of a significant difference in the MVC/ACSA between
smokers and non-smokers (Table 2). Also, the level of
voluntary activation and co-activation of the antagonist
muscles during an MVC were not significantly different
between smokers and non-smokers (Table 2).
Contractile properties
The contraction times of the 100-Hz tetani were not
significantly different between the smokers and non-
smokers (Table 2). Similarly, half relaxation time was
comparable in the two groups. In line with this the
frequency–torque relationship of the quadriceps of
smokers and non-smokers showed no difference (Fig. 1).
Fatigue index
In Figure 2 it can be seen that the quadriceps muscles of
the smokers were more susceptible to fatigue than those
of the non-smokers (P < 0.05); after 2 min of 30-Hz
stimulation the FI was 0.54  0.08 vs. 0.62  0.09 in
Table 2 Quadriceps function and contractile characteristics
from male smokers and non-smokers
Smokers
(n ¼ 9)
Non-smokers
(n ¼ 10)
MVC (Nm) 335  73 351  72
ACSA (cm2) 74.9  11.6 78.9  6.7
MVC/ACSA (Nm cm)2) 4.5  0.5 4.5  0.9
Activation (%) 92  3 93  9
Co-activation (%) 27  17 18  10
Contraction time (ms) 334  125 293  67
1
2 Relaxation time (ms) 112  6 117  8
MVC, maximal voluntary isometric knee extension torque;
ACSA, anatomical cross-sectional area; MVC/ACSA, MVC
torque relative to ACSA; for further details see the Methods.
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Figure 1 The frequency–torque relationship in healthy young
male smokers (S) and non-smokers (C). T/T0: Torque at a
certain frequency as a percentage of the torque at 100 Hz.
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Figure 2 Fatigue resistance of the quad-
riceps muscle in healthy young male
smokers (S) and non-smokers (C). The
torque (T/T0), elicited by electrical sti-
mulation (30-Hz, 1-s on 1-s off) of the
quadriceps muscle, is presented as relative
to the torque generated during the first
contraction. The torque decline was lar-
ger in smokers than non-smokers
(P < 0.05).
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smokers and non-smokers respectively. The variation in
FI among the smokers did not correlate with either
smoking volume in terms of pack years (R2 ¼ 0.09,
P > 0.05) or FEV1%pred (R
2 ¼ 0.28, P > 0.05).
Discussion
The main finding of the present study was a decrease in
fatigue resistance in young male smokers compared
with a group of physical activity-matched non-smokers,
while strength and other contractile properties did not
differ between the groups. Based on the present results
the decrease in fatigue resistance cannot be explained by
disuse, or restricted airflow. The electrically stimulated
fatigue test eliminates the possibility that differences in
fatiguability are due to differences in motivation and it
is probable that the cause of the lower fatigue resistance
in smokers is located within the muscle, at or beyond
the level of the neuromuscular junction.
Strength
We observed no differences in knee extension strength
between smokers and non-smokers. Two other studies,
however, have reported a decline in maximal voluntary
strength in smokers (O¨rlander et al. 1979, Al-Obaidi
et al. 2004). Such a decline can, at least theoretically, be
a consequence of a smaller muscle mass, a reduced
ability to voluntarily activate the muscle and/or
increased activation of antagonistic muscles during a
maximal contraction. These factors could be secondary
to lower levels of activity in the smokers in these
previous studies. Indeed, it has been suggested that a
lower level of physical activity underlies the decline in
strength previously observed in smokers (O¨rlander et al.
1979). In the present study smokers and non-smokers
were matched for physical activity level and, similarly to
Larsson et al. (Larsson 1984), we did not observe a
difference in strength between smokers and non-smok-
ers. Thus, the decrease in strength observed in previous
studies is likely to be explicable by a reduced activity
level in smokers, rather than an effect of smoking per se
on maximal knee extensor strength or other determi-
nants of strength (activation, co-activation and ACSA).
Fatigue
Although strength was not affected by smoking, the
fatigue resistance of the quadriceps muscle was signifi-
cantly reduced. Others, however, have not observed a
change in the fatigue resistance during maximal volun-
tary contractions in smokers (O¨rlander et al. 1979,
Larsson 1984). This discrepancy is difficult to explain
but may, in part, be related to the type of fatigue tests
performed. Previous studies have used a series of fast
dynamic contractions where the recovery interval
between contractions was probably around half a
second compared to the 1-s interval in the present
study. Dynamic contractions are more energetically
demanding than the isometric contractions we have
used. Consequently previous work may have been
testing predominantly anaerobic function whilst our
protocol emphasizes more the aerobic capacity of the
muscle and the ability to recover between successive
contractions.
The acute neural stimulation effect of nicotine in
cigarette smoke is well established (Cryer et al. 1976)
and Mundel & Jones (2006) have demonstrated that
nicotine has a beneficial effect on cycling endurance. It
might be hypothesised that the stimulant effect of
nicotine during voluntary fatigue tests may counteract
some peripheral mechanism which contributed to the
greater levels of fatigue in the smokers in the present
study.
Smoking is the primary cause of COPD, which is
characterized by a decline in FEV1, and it has been
reported that smoking itself causes an increase in
pulmonary airway resistance (Nadel & Comroe
1961). However, we did not observe a significantly
lower FEV1%pred in smokers than non-smokers, or any
correlation between fatigue resistance and FEV1%pred.
Therefore it is unlikely that lung function and the ability
to oxygenate the blood play any role in the lower
fatigue resistance of smokers. Indeed, as the fatigue test
was performed on one leg, with activation of only about
30% of the quadriceps, blood oxygenation is unlikely to
be a limiting factor.
Lower levels of habitual physical activity level might
lead to reduced oxidative capacity but in the present
investigation the similar activity levels suggest that it is
cigarette smoking itself which is responsible for the
observed reduction in fatigue resistance.
A number of mechanisms (both acute and chronic)
may be responsible for the observed decline in fatigue
resistance, these include alterations in muscle fibre type
composition and/or a decreased oxidative capacity
(O¨rlander et al. 1979, Larsson 1984).
Although the frequency–torque relationship and
contraction and relaxation times are not unequivocal
indicators for changes in fibre type composition, the
absence of significant alterations in these parameters
indicates no major changes in fibre type composition.
Mitochondrial enzyme activities (citrate synthase and
3-hydroxyacyl-CoA dehydrogenase) have been reported
to be decreased in the muscles of smokers (O¨rlander
et al. 1979). Interestingly, healthy ex-smokers did not
show a decline in activities of enzymes of oxidative
metabolism (Larsson 1984) and COPD patients who
stopped smoking exhibited normal fatigue resistance
(Degens et al. 2005). This suggests that the smoking-
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induced alterations in the activity of oxidative enzymes
and muscle fatigue resistance are reversible. Further-
more, the fact that we found no relationship between
pack years and fatigue resistance suggests an acute
effect of smoking. Cyanide and carbon monoxide (CO),
in smoke are possible candidates for acutely affecting
fatigue resistance. Cyanide and CO inhibit cytochrome
c oxidase (complex IV in the mitochondrial chain),
causing an overall decline in mitochondrial function
and oxidative capacity (Alonso et al. 2003), and thus
potentially a reduced fatigue resistance of the muscle.
Beside acting on cytochrome c oxidase, CO in
cigarette smoke increases Carboxyhemoglobin (COHb)
levels (Puente-Maestu et al. 1998), which reduces the
O2 carrying capacity of the blood. However, a reduced
O2 carrying capacity of the blood induced by breathing
hypoxic air had no effect on fatigue resistance during
the same test as employed in the present study (Degens
et al. 2006). COHb also hampers the release of O2 as
reflected by the left-ward shift of the O2-Hb binding
curve. Furthermore, the facilitated diffusion of O2 by
myoglobin within the muscle may be impaired by the
formation of carboxymyoglobin (Wittenberg & Witten-
berg 1987). It has been reported that raised levels of
COHb reduce O2 extraction during stimulated contrac-
tions with in situ canine gastrocnemius, which was
accompanied by a reduction in muscle tension (King
et al. 1987).
Besides changes in the muscle itself, another possi-
bility for the earlier onset of fatigue in smokers might be
related to neurotransmission failure (Gandevia 2001).
Using direct muscle stimulation superimposed on nerve
stimulation, it has been shown that neurotransmission
failure contributes to an earlier onset of fatigue during
hypoxia (Zhu et al. 2006). With the present stimulation
protocol we are unable to state whether neural trans-
mission failure contributed to the earlier onset of fatigue
in smokers.
We assume that the more rapid fatigue, whatever the
cause, is a consequence of changes occurring as a result
of smoking. However, we cannot exclude the possibility
that there may be some genetic component that, for
instance, influences the likelihood of smoking and, at
the same time, influences fatigue properties of the
muscle.
The relationship between the changes in fatigue
resistance we report here and the muscle dysfunction
frequently seen in COPD patients is unclear. Given that
fatigue resistance is not affected in COPD patients who
stopped smoking (Degens et al. 2005) and the fact that
we saw no association between pack years smoked and
FI, it is likely that the reduced fatigue resistance in the
present smokers is acute in nature. If it is an acute
response, the underlying factors of this fatigue are most
likely changes in the oxidative capacity of the muscle
brought about, for instance, by a reversible effect of
cyanide and/or CO on mitochondrial enzyme function
and tissue oxygenation. Indeed, 28 days of smoking
cessation has been shown to result in a return to normal
mitochondrial respiratory chain function (Cardellach
et al. 2003). Therefore, future studies may be directed
towards the acute effects of CO, smoking and smoking
cessation on skeletal muscle function, oxygenation and
fatigue resistance.
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